tiprankstipranks
Advertisement
Advertisement

DOCS, WIX, CAKE, SBUX, VRT Trending With Analysts

DOCS, WIX, CAKE, SBUX, VRT Trending With Analysts

Analysts are intrested in these 5 stocks: ( (DOCS) ), ( (WIX) ), ( (CAKE) ), ( (SBUX) ) and ( (VRT) ). Here is a breakdown of their recent ratings and the rationale behind them.

Claim 55% Off TipRanks

Doximity is suddenly out of favor with Wall Street, as two major firms stepped back on the same day. Jefferies’ Brian Tanquilut cut DOCS to Hold with a $19 target, arguing that weak pharma advertising demand and heavy AI spending are likely to keep the stock stuck in a “penalty box” until at least FY28, despite the company’s leadership position in physician-focused digital marketing.

He sees pharma ad budgets as too soft to support a clear revenue rebound exiting 2026, and believes DOCS’ long‑term growth is closer to 9%, implying a lower valuation multiple. Baird’s Vikram Kesavabhotla also moved to Neutral with an $18 target, warning that AI investments will take a long time to prove out, while competitive pressure, leadership changes and only about 65% of FY27 revenue booked leave both estimates and valuation exposed to further downside.

Wix is another tech name where optimism about AI is clashing with near‑term profitability concerns. Citi’s Jamesmichael Sherman‑Lewis downgraded WIX from Buy to Neutral with a $66 target, citing softer revenue growth in the Partners segment, elevated marketing costs to fuel the fast‑growing Base44 product and AI‑related computing expenses that are pressuring margins, even as the company delivers strong customer acquisition and product momentum.

Base44’s annual recurring revenue has surged to about $150 million, up roughly 50% in just two months, and new user cohort bookings are growing rapidly as Wix leans into AI‑driven tools like Harmony and proprietary models to cut compute costs. Still, the analyst thinks these growth levers come with structurally lower margins and limited visibility, making Wix more of a “wait‑and‑see” story for investors watching how its FY26 mid‑teens growth ambitions collide with macro and partner headwinds.

Cheesecake Factory, by contrast, is winning cautious respect for steady execution in a tough dining backdrop. J.P. Morgan’s John Ivankoe upgraded CAKE from Underweight to Neutral with a $68 price target, pointing to modest same‑store sales growth at the flagship brand and standout performance at Flower Child, alongside industry‑low employee turnover and limited casual‑dining supply growth that help support margins and cash generation.

The analyst now sees a clearer path to margin expansion in 2026 and 2027, backed by around 7% unit growth (but lower square footage growth as newer boxes are smaller), improved marketing, and the launch of a dedicated mobile app aimed at boosting traffic and frequency. Flower Child is a key upside lever, with its future network valued at hundreds of millions of dollars, while management is expected to generate solid cash flow and keep leverage at manageable levels, making CAKE a more balanced risk/reward than before.

Starbucks, meanwhile, has moved back into market darling territory for at least one influential analyst. Guggenheim’s Andrew Charles upgraded SBUX to Buy with a $120 price target, arguing that the coffee giant is only in the early stages of a North American revitalization plan driven by better operations, sharper marketing, menu innovation and loyalty enhancements, all guided by a leadership team with a strong track record from Taco Bell.

He is now modeling higher same‑store sales and margin recovery than consensus, helped by labor investments that should translate into better execution, easing coffee costs and a $2 billion cost‑savings program. On that basis, he expects Starbucks to deliver earnings above Street forecasts through 2028 and sees room for the stock to justify a premium multiple as the company defends a dominant share in a resilient coffee category even as the broader restaurant environment remains choppy.

Vertiv Holdings has burst into the spotlight as a pure‑play beneficiary of the AI data‑center boom. Loop Capital’s Ananda Baruah initiated coverage of VRT with a Buy rating and a bold $500 price target, framing the company not as a traditional industrial but as a technology innovator at the heart of power and cooling solutions for AI infrastructure, with more than 70% of revenue already tied to data centers.

The report argues that Vertiv has built a powerful “flywheel” by rapidly innovating modular, AI‑ready solutions and winning a place in what the analyst calls the Gen AI “Cool Kids Club,” alongside leading chip and hardware vendors. With AI compute spending and accelerator deployments expected to explode through 2028, Baruah sees Vertiv as an underappreciated winner whose earnings power and strategic position could surprise the market to the upside as the AI infrastructure super‑cycle unfolds.

Disclaimer & DisclosureReport an Issue

1